Hormone Replacement Therapy Current Events | Hormone Replacement Therapy News | 3
|
| Page
3 of
66 |
1306 Results |
|
|
|
Sort By:
Page Views | Date |
Hormone replacement therapy may improve trip down memory lane
Many women experience declines in their memory during and after menopause, a change thought to be due, in part, to the rapid hormonal changes they weather during that time. view more (2006-11-17)
Treatment discovered for deadly childhood disease
Researchers have discovered that a treatment involving enzyme replacement therapy dramatically reduces the risk of death in children with Pompe disease, a rare genetic disorder in which most children die before their first birthday. view more (2006-12-07)
Drug reverses bone loss in men with prostate cancer during the first year of treatment
A common type of treatment used to protect bone density in menopausal women is also an effective therapy for advanced prostate cancer patients during the first year of hormone therapy. view more (2006-02-27)
Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. view more (2008-01-02)
LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
Combined hormone therapy appears to increase the risk that women will have abnormal mammograms and breast biopsies, and it may decrease the effectiveness of both methods for detecting breast cancer. view more (2008-02-26)
Secret herb in tests to stop breast cancer patients' hot flushes and night sweats
Researchers at the University of Manchester are testing a secret herb in a bid to stop the severe hot flushes that besiege breast cancer patients on hormone treatment. view more (2006-04-28)
Hormone therapy before radiation seed implants for prostate cancer
Men over 70 years of age with early-stage prostate cancer have 20 percent higher mortality if they are treated first with hormone therapy before being treated with radiation seed implants (brachytherapy), compared to men who are treated with brachytherapy alone. view more (2008-09-23)
Why prostate cancer patients fail hormone deprivation therapy
The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. view more (2009-01-05)
Walking prevents bone loss caused from prostate cancer treatment
Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men. view more (2007-10-29)
Prostate cancer vaccines more effective with hormone therapy
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for... view more... (2008-07-10)
Testosterone therapy may prevent Alzheimer's disease
Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease. view more (2006-12-20)
Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone. view more (2009-11-03)
Effect of hormone therapy on risk of heart disease may vary by age and years since menopause
Secondary analyses of findings from the Womenˇ¦s Health Initiative (WHI) suggest that women who begin hormone therapy within 10 years of menopause may have less risk of coronary heart disease (CHD) due to hormone therapy than women farther from menopause. view more (2007-04-04)
Androgen therapy may slow progress of Alzheimer's disease
Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression. view more (2006-12-20)
Pituitary hormone implicated in bone loss after menopause
New evidence in the April 21, 2006 Cell challenges the long-standing notion that declining estrogen levels alone lead to osteoporosis after women go through menopause. view more (2006-04-21)
Estrogen-progestin menopausal hormone therapy and risk of lobular and tubular breast cancer
Estrogen-progestin menopausal hormone therapy is associated with a more than two-fold higher relative risk of developing lobular cancer or tubular cancer than of developing ductal cancer. view more (2006-02-17)
Women on hormone therapy regain emotion response
Older women on hormone therapy are more sensitive to negative events, confirming speculation that age-related estrogen loss affects the brain's ability to process emotion, an Oregon Health & Science University study shows. view more (2006-10-17)
Further Evidence That Hrt Does Not Protect Against Cardiovascular Disease (p 2001)
Results of a UK randomised trial published in this week's issue of THE LANCET provides further evidence that hormone replacement therapy (HRT) does not offer women protection against cardiovascular disease. Previous observational studies have suggested that HRT could reduce the risk of coronary heart disease (CHD), but results of randomised trials... view more... (2002-12-18)
Ethnic variations in hormone levels may cause differences in breast cancer risk
Researchers have known that a woman's natural hormone levels can affect her risk of developing breast cancer. A new study from the University of Southern California (USC) has found that the natural levels of estrogens in post-menopausal women varies by ethnicity and race, and may explain the differences in the groups' breast cancer rates. view more (2006-10-10)
Speed of PSA rise helps predict survival for prostate cancer patients
The clinical outcome for prostate cancer patients who have been treated with hormone therapy and radiation therapy can usually be determined by how rapidly their prostate specific antigen level rises following treatment. view more (2005-10-03)
|
|
| Page
3 of
66 |
1306 Results |
|
|
|
Sort By:
Page Views | Date |
|
